HCV NS5A replication complex inhibitors. Part 5: Discovery of potent and pan-genotypic glycinamide cap derivatives-Reference-Cited by-同舟云学术

HCV NS5A replication complex inhibitors. Part 5: Discovery of potent and pan-genotypic glycinamide cap derivatives

Published:2013-08 Issue:15 Volume:23 Page:4428-4435
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Belema Makonen,Nguyen Van N.,St. Laurent Denis R.,Lopez Omar D.,Qiu Yuping,Good Andrew C.,Nower Peter T.,Valera Lourdes,O’Boyle Donald R.,Sun Jin-Hua,Liu Mengping,Fridell Robert A.,Lemm Julie A.,Gao Min,Knipe Jay O.,Meanwell Nicholas A.,Snyder Lawrence B.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference31 articles.

1. Global surveillance and control of hepatitis C

2. Global epidemiology of hepatitis C virus infection

3. Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008

4. Genetic diversity and evolution of hepatitis C virus – 15 years on

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Discovery and Development of Daclatasvir: An Inhibitor of the Hepatitis C Virus NS5A Replication Complex;Topics in Medicinal Chemistry;2019

2. Sulfur(vi) fluoride exchange as a key reaction for synthesizing biaryl sulfate core derivatives as potent hepatitis C virus NS5A inhibitors and their structure–activity relationship studies;RSC Advances;2018

3. Direct-Acting Antiviral Agents for the Treatment of Hepatitis C Virus Infection;Comprehensive Medicinal Chemistry III;2017

4. 2015 Philip S. Portoghese Medicinal Chemistry Lectureship. Curing Hepatitis C Virus Infection with Direct-Acting Antiviral Agents: The Arc of a Medicinal Chemistry Triumph;Journal of Medicinal Chemistry;2016-08-08

5. Biotransformation of Daclatasvir In Vitro and in Nonclinical Species: Formation of the Main Metabolite by Pyrrolidine -Oxidation and Rearrangement;Drug Metabolism and Disposition;2016-03-30